Rethinking ovarian cancer: Recommendations for improving outcomes Journal Article


Authors: Vaughan, S.; Coward, J. I.; Bast, R. C.; Berchuck, A.; Berek, J. S.; Brenton, J. D.; Coukos, G.; Crum, C. C.; Drapkin, R.; Etemadmoghadam, D.; Friedlander, M.; Gabra, H.; Kaye, S. B.; Lord, C. J.; Lengyel, E.; Levine, D. A.; McNeish, I. A.; Menon, U.; Mills, G. B.; Nephew, K. P.; Oza, A. M.; Sood, A. K.; Stronach, E. A.; Walczak, H.; Bowtell, D. D.; Balkwill, F. R.
Article Title: Rethinking ovarian cancer: Recommendations for improving outcomes
Abstract: There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene Harris Memorial Trust meeting, an international group of researchers considered actions that should be taken to improve the outcome for women with ovarian cancer. Nine major recommendations are outlined in this Opinion article. © 2011 Macmillan Publishers Limited. All rights reserved.
Keywords: cancer survival; treatment outcome; review; cancer localization; bevacizumab; cisplatin; doxorubicin; cancer risk; antineoplastic agents; clinical trials as topic; drug targeting; hysterectomy; t lymphocyte; ovarian neoplasms; biological marker; animals; carboplatin; cancer immunotherapy; consensus; quality of life; ovary cancer; ovariectomy; epidermal growth factor receptor 2; genetic association; cancer screening; cyclophosphamide; melphalan; diagnostic imaging; brca1 protein; brca2 protein; protein p53; cancer research; histology; health planning guidelines; early diagnosis; gene identification; practice guidelines as topic; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor; nomenclature; ca 125 antigen; taxane derivative; rad51 protein; olaparib; international cooperation; scatter factor receptor; tumor microenvironment; clinical trial (topic); study design; salpingectomy
Journal Title: Nature Reviews Cancer
Volume: 11
Issue: 10
ISSN: 1474-175X
Publisher: Nature Publishing Group  
Date Published: 2011-09-23
Start Page: 719
End Page: 725
Language: English
DOI: 10.1038/nrc3144
PROVIDER: scopus
PUBMED: 21941283
PMCID: PMC3380637
DOI/URL:
Notes: --- - "Export Date: 2 November 2011" - "CODEN: NRCAC" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Douglas A Levine
    380 Levine